Elevation Oncology Statistics

Total Valuation

ELEV has a market cap or net worth of $34.29 million. The enterprise value is -$37.76 million.

Market Cap	34.29M
Enterprise Value	-37.76M

Important Dates

The last earnings date was Wednesday, November 6, 2024, before market open.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

ELEV has 59.12 million shares outstanding. The number of shares has increased by 81.44% in one year.

Current Share Class	59.12M
Shares Outstanding	59.12M
Shares Change (YoY)	+81.44%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	1.70%
Owned by Institutions (%)	61.14%
Float	38.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.49
P/TBV Ratio	0.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.77, with a Debt / Equity ratio of 0.45.

Current Ratio	17.77
Quick Ratio	17.39
Debt / Equity	0.45
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-10.11

Financial Efficiency

Return on equity (ROE) is -63.67% and return on invested capital (ROIC) is -27.24%.

Return on Equity (ROE)	-63.67%
Return on Assets (ROA)	-25.46%
Return on Capital (ROIC)	-27.24%
Revenue Per Employee	n/a
Profits Per Employee	-$1.45M
Employee Count	29
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ELEV has paid $43,000 in taxes.

Income Tax	43,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.48% in the last 52 weeks. The beta is 1.25, so ELEV's price volatility has been higher than the market average.

Beta (5Y)	1.25
52-Week Price Change	+20.48%
50-Day Moving Average	0.60
200-Day Moving Average	2.17
Relative Strength Index (RSI)	43.92
Average Volume (20 Days)	862,338

Short Selling Information

The latest short interest is 6.13 million, so 10.38% of the outstanding shares have been sold short.

Short Interest	6.13M
Short Previous Month	6.02M
Short % of Shares Out	10.38%
Short % of Float	15.93%
Short Ratio (days to cover)	9.52

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-42.01M
Pretax Income	-39.66M
Net Income	-41.95M
EBITDA	-41.98M
EBIT	-42.01M
Earnings Per Share (EPS)	-$0.79

Full Income Statement

Balance Sheet

The company has $103.07 million in cash and $31.02 million in debt, giving a net cash position of $72.05 million or $1.22 per share.

Cash & Cash Equivalents	103.07M
Total Debt	31.02M
Net Cash	72.05M
Net Cash Per Share	$1.22
Equity (Book Value)	69.36M
Book Value Per Share	1.17
Working Capital	99.40M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-38.34M
Capital Expenditures	n/a
Free Cash Flow	-38.34M
FCF Per Share	-$0.65

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELEV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-81.44%
Shareholder Yield	-81.44%
Earnings Yield	-122.34%
FCF Yield	-111.82%

Analyst Forecast

The average price target for ELEV is $7.20, which is 1,141.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.20
Price Target Difference	1,141.38%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2